SAVANNAH WOMACK: Open Payments
NPI 1780464487 · ENTERPRISE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,383 in 75 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $1,241 · 2025 $1,383
Food & beverage: $1,197Education: $185
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $310 |
| ABBVIE INC. | 16 | $282 |
| Regeneron Healthcare Solutions, Inc. | 9 | $269 |
| UCB, Inc. | 25 | $268 |
| GENZYME CORPORATION | 8 | $170 |
| Lilly USA, LLC | 1 | $25 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
| Galderma Laboratories, L.P. | 1 | $14 |
Products named: DUPIXENT, TREMFYA, Bimzelx, SKYRIZI, RINVOQ, EBGLYSS, Rhapsido, Sotyktu.
Industry payments across AL — which companies pay providers there.
